Gyamlani Geeta G, Bergstralh Erik J, Slezak Jeffrey M, Larson Timothy S
Department of Medicine, Division of Nephrology, Mayo Clinic and Foundation, Rochester, MN 55905, USA.
Am J Kidney Dis. 2003 Oct;42(4):685-92. doi: 10.1016/s0272-6386(03)00830-8.
Urinary albumin to creatinine ratio (ACR) in a single urine sample has been proposed to provide an estimate of microalbuminuria by adjusting for variability in urine concentrations. We hypothesized that adjusting the urine albumin concentration of single-void specimens for actual urine osmolality (urinary albumin to osmolality ratio [AOR]) may provide a more accurate estimate of 24-hour urine albumin excretion rates (AERs).
Patients with diabetes mellitus (DM; n = 136) had urinary concentrations of albumin, glucose, and creatinine and osmolality measured on single-void samples, and albumin levels, on 24-hour samples. Microalbuminuria is defined as an AER between 30 and 300 mg/d.
Correlation between AOR on single-void samples and AER on 24-hour samples (r = 0.87; P < 0.001) was similar to that between ACR and AER (r = 0.88; P < 0.001). Using a cutoff value of 18.4 mg/kg/mOsm x 10(2) (18.4 mg/mmol x 10(2)) for AOR resulted in a sensitivity and specificity of 82% and 86% in detecting microalbuminuria, respectively. The area under the curve (AUC) for AOR was 0.89. Using a cutoff value of 15.0 mg/g (1.7 mg/mmol) for ACR resulted in a sensitivity and specificity of 85% and 85% in detecting microalbuminuria, respectively. The AUC for ACR was 0.90. The ability of AOR to predict AER was maintained at varying degrees of glycosuria (glucose < 100 mg/dL [<5.5 mmol/L]; r = 0.77; 100 to 750 mg/dL [5.5 to 42 mmol/L]; r = 0.85; and >750 mg/dL [>42 mmol/L]; r = 0.92).
Urinary AOR correlates closely with 24-hour microalbuminuria determination, and the correlation is not appreciably affected by glycosuria. Thus, AOR can be used as an alternative test to ACR in the assessment of microalbuminuria in the population with DM.
有人提出通过对单次尿液样本中的尿白蛋白与肌酐比值(ACR)进行调整,以校正尿液浓度的变异性,从而估算微量白蛋白尿。我们假设根据实际尿渗透压对单次排尿样本的尿白蛋白浓度进行调整(尿白蛋白与渗透压比值[AOR]),可能会更准确地估算24小时尿白蛋白排泄率(AER)。
对136例糖尿病(DM)患者的单次排尿样本测量尿白蛋白、葡萄糖、肌酐浓度及渗透压,对24小时样本测量白蛋白水平。微量白蛋白尿定义为AER在30至300mg/d之间。
单次排尿样本的AOR与24小时样本的AER之间的相关性(r = 0.87;P < 0.001)与ACR和AER之间的相关性(r = 0.88;P < 0.001)相似。使用AOR的临界值18.4mg/kg/mOsm×10²(18.4mg/mmol×10²)检测微量白蛋白尿的敏感性和特异性分别为82%和86%。AOR的曲线下面积(AUC)为0.89。使用ACR的临界值15.0mg/g(1.7mg/mmol)检测微量白蛋白尿的敏感性和特异性分别为85%和85%。ACR的AUC为0.90。在不同程度的糖尿情况下(葡萄糖<100mg/dL [<5.5mmol/L];r = 0.77;100至750mg/dL [5.5至42mmol/L];r = 0.85;>750mg/dL [>42mmol/L];r = 0.92),AOR预测AER的能力均得以维持。
尿AOR与24小时微量白蛋白尿测定密切相关,且这种相关性不受糖尿的明显影响。因此,在评估糖尿病患者的微量白蛋白尿时,AOR可作为ACR的替代检测方法。